Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast.

PubWeight™: 1.72‹?› | Rank: Top 3%

🔗 View Article (PMID 7682896)

Published in Cell on April 23, 1993

Authors

J L Teem1, H A Berger, L S Ostedgaard, D P Rich, L C Tsui, M J Welsh

Author Affiliations

1: Howard Hughes Medical Institute, University of Iowa College of Medicine, Department of Internal Medicine, Iowa City 52242.

Articles citing this

Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. EMBO J (1994) 2.93

Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences. Cell (2012) 1.81

Mechanism-based corrector combination restores ΔF508-CFTR folding and function. Nat Chem Biol (2013) 1.76

Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function. Cell (2012) 1.73

Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms. Proc Natl Acad Sci U S A (2006) 1.56

The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis. J Biol Chem (2010) 1.55

Human SEC13Rp functions in yeast and is located on transport vesicles budding from the endoplasmic reticulum. J Cell Biol (1995) 1.54

Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect. PLoS Biol (2016) 1.42

Regulatory insertion removal restores maturation, stability and function of DeltaF508 CFTR. J Mol Biol (2010) 1.31

VX-809 corrects folding defects in cystic fibrosis transmembrane conductance regulator protein through action on membrane-spanning domain 1. Mol Biol Cell (2013) 1.29

Mutational disruption of plasma membrane trafficking of Saccharomyces cerevisiae Yor1p, a homologue of mammalian multidrug resistance protein. Mol Cell Biol (1999) 1.26

Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1. Protein Sci (2010) 1.25

Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. J Clin Invest (1994) 1.20

Restoration of domain folding and interdomain assembly by second-site suppressors of the DeltaF508 mutation in CFTR. FASEB J (2010) 1.18

Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR. J Mol Biol (2012) 1.18

Building an understanding of cystic fibrosis on the foundation of ABC transporter structures. J Bioenerg Biomembr (2007) 1.14

Biogenesis of the Saccharomyces cerevisiae pheromone a-factor, from yeast mating to human disease. Microbiol Mol Biol Rev (2012) 1.13

NMR evidence for differential phosphorylation-dependent interactions in WT and DeltaF508 CFTR. EMBO J (2009) 1.12

Cystic fibrosis: a disease of altered protein folding. J Bioenerg Biomembr (1997) 1.12

Diminished self-chaperoning activity of the DeltaF508 mutant of CFTR results in protein misfolding. PLoS Comput Biol (2008) 1.08

Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules. Proc Natl Acad Sci U S A (2013) 1.05

Linking yeast genetics to mammalian genomes: identification and mapping of the human homolog of CDC27 via the expressed sequence tag (EST) data base. Proc Natl Acad Sci U S A (1993) 1.05

Structural and functional similarities between the nucleotide-binding domains of CFTR and GTP-binding proteins. Biophys J (1995) 1.04

Thermally unstable gating of the most common cystic fibrosis mutant channel (ΔF508): "rescue" by suppressor mutations in nucleotide binding domain 1 and by constitutive mutations in the cytosolic loops. J Biol Chem (2011) 1.04

Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity. Biochemistry (2012) 1.01

Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR. J Physiol (2014) 1.00

Modeling of nucleotide binding domains of ABC transporter proteins based on a F1-ATPase/recA topology: structural model of the nucleotide binding domains of the cystic fibrosis transmembrane conductance regulator (CFTR). J Bioenerg Biomembr (1997) 0.99

Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations? BMC Med Genet (2004) 0.99

Ligand-driven vectorial folding of ribosome-bound human CFTR NBD1. Mol Cell (2011) 0.97

Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am J Hum Genet (1995) 0.97

Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization. J Biol Chem (2015) 0.97

Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein. J Bioenerg Biomembr (1997) 0.94

Probing conformational rescue induced by a chemical corrector of F508del-cystic fibrosis transmembrane conductance regulator (CFTR) mutant. J Biol Chem (2011) 0.93

A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype. Hum Genet (2005) 0.93

Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum. Proc Natl Acad Sci U S A (1995) 0.93

Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains. Protein Sci (2014) 0.91

Mechanisms of CFTR Folding at the Endoplasmic Reticulum. Front Pharmacol (2012) 0.90

Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator. J Biol Chem (2012) 0.89

Interplay between ER exit code and domain conformation in CFTR misprocessing and rescue. Mol Biol Cell (2009) 0.89

Targets for cystic fibrosis therapy: proteomic analysis and correction of mutant cystic fibrosis transmembrane conductance regulator. Expert Rev Proteomics (2010) 0.89

Allosteric coupling between the intracellular coupling helix 4 and regulatory sites of the first nucleotide-binding domain of CFTR. PLoS One (2013) 0.89

Human-mouse cystic fibrosis transmembrane conductance regulator (CFTR) chimeras identify regions that partially rescue CFTR-ΔF508 processing and alter its gating defect. Proc Natl Acad Sci U S A (2011) 0.87

Cystic fibrosis transmembrane conductance regulator (ABCC7) structure. Cold Spring Harb Perspect Med (2013) 0.87

Intragenic suppressing mutations correct the folding and intracellular traffic of misfolded mutants of Yor1p, a eukaryotic drug transporter. J Biol Chem (2010) 0.86

Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability. Cold Spring Harb Perspect Med (2013) 0.83

Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly. J Mol Biol (2014) 0.82

Synonymous codon usage affects the expression of wild type and F508del CFTR. J Mol Biol (2015) 0.81

Rational Coupled Dynamics Network Manipulation Rescues Disease-Relevant Mutant Cystic Fibrosis Transmembrane Conductance Regulator. Chem Sci (2015) 0.79

The cystic-fibrosis-associated ΔF508 mutation confers post-transcriptional destabilization on the C. elegans ABC transporter PGP-3. Dis Model Mech (2012) 0.78

Biochemical and biophysical approaches to probe CFTR structure. Methods Mol Biol (2011) 0.78

Characterization of an allele-nonspecific intragenic suppressor in the yeast plasma membrane H+-ATPase gene (Pma1). Genetics (1998) 0.78

Development of CFTR Structure. Front Pharmacol (2012) 0.77

Saccharomyces cerivisiae as a model system for kidney disease: what can yeast tell us about renal function? Am J Physiol Renal Physiol (2011) 0.77

Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation. J Biol Chem (2015) 0.76

Comparison of the bacterial HelA protein to the F508 region of the cystic fibrosis transmembrane regulator. J Bacteriol (1997) 0.75

Decoding F508del misfolding in cystic fibrosis. Biomolecules (2014) 0.75

Complement yourself: Transcomplementation rescues partially folded mutant proteins. Biophys Rev (2014) 0.75

Novel CFTR Mutations in Two Iranian Families with Severe Cystic Fibrosis. Iran Biomed J (2016) 0.75

Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy. Protein Sci (2016) 0.75

Articles by these authors

Identification of the cystic fibrosis gene: genetic analysis. Science (1989) 33.61

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature (2000) 10.32

Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature (1992) 8.47

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell (1996) 6.84

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet (1997) 6.83

Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science (1991) 5.82

Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science (1985) 5.81

Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nat Genet (1996) 5.70

A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature (1990) 5.42

A polymorphic DNA marker linked to cystic fibrosis is located on chromosome 7. Nature (1985) 5.07

Structure and function of the CFTR chloride channel. Physiol Rev (1999) 4.82

The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508). N Engl J Med (1990) 4.70

Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med (1990) 4.60

A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet (2001) 4.58

Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem (1995) 4.39

Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 4.27

Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature (1990) 4.26

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13

Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85

Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel. Cell (1991) 3.75

Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell (1990) 3.70

Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development (1997) 3.66

Expression of the cystic fibrosis gene in non-epithelial invertebrate cells produces a regulated anion conductance. Cell (1991) 3.56

The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice. Neuron (2001) 3.56

Identification of Sonic hedgehog as a candidate gene responsible for holoprosencephaly. Nat Genet (1996) 3.50

Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell (1993) 3.47

Generation of cAMP-activated chloride currents by expression of CFTR. Science (1991) 3.45

Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties. Nature (1993) 3.43

Cone-rod dystrophy due to mutations in a novel photoreceptor-specific homeobox gene (CRX) essential for maintenance of the photoreceptor. Cell (1997) 3.42

The mammalian sodium channel BNC1 is required for normal touch sensation. Nature (2000) 3.30

Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet (1995) 3.27

Nucleoside triphosphates are required to open the CFTR chloride channel. Cell (1991) 3.21

Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem (2001) 3.15

Multi-ion pore behaviour in the CFTR chloride channel. Nature (1993) 3.14

A suggested nomenclature for designating mutations. Hum Mutat (1993) 3.10

Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature (1990) 3.09

Cyclic AMP-dependent protein kinase opens chloride channels in normal but not cystic fibrosis airway epithelium. Nature (1988) 3.06

Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J Biol Chem (1999) 3.04

Calcium-dependent regulator protein: localization in mitotic apparatus of eukaryotic cells. Proc Natl Acad Sci U S A (1978) 3.03

Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5. Nucleic Acids Res (2001) 2.89

The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity. J Biol Chem (1995) 2.88

High-resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc Natl Acad Sci U S A (1992) 2.72

Rapid nonradioactive detection of the major cystic fibrosis mutation. Am J Hum Genet (1990) 2.72

Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem (1993) 2.69

A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins. Proc Natl Acad Sci U S A (1998) 2.68

Crypts are the site of intestinal fluid and electrolyte secretion. Science (1982) 2.66

Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet (1996) 2.65

A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet (1993) 2.64

Introduction and recovery of a selectable bacterial gene from the genome of mammalian cells. Mol Cell Biol (1982) 2.59

A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene (1993) 2.59

Membrane topology of the amiloride-sensitive epithelial sodium channel. J Biol Chem (1994) 2.56

Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol (2000) 2.55

Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J Gen Physiol (1992) 2.53

Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo. J Clin Invest (1998) 2.51

Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet (1998) 2.51

A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest (1995) 2.48

Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet (1992) 2.48

Mechanism by which Liddle's syndrome mutations increase activity of a human epithelial Na+ channel. Cell (1995) 2.47

Cloning and expression of the beta- and gamma-subunits of the human epithelial sodium channel. Am J Physiol (1995) 2.38

Modes of DAPI banding and simultaneous in situ hybridization. Chromosoma (1993) 2.38

Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease. N Engl J Med (1990) 2.37

Tubulin and calmodulin. Effects of microtubule and microfilament inhibitors on localization in the mitotic apparatus. J Cell Biol (1979) 2.35

Chloride and potassium channels in cystic fibrosis airway epithelia. Nature (1986) 2.34

Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection. J Clin Invest (1997) 2.33

Characterization of the human beta-crystallin gene Hu beta A3/A1 reveals ancestral relationships among the beta gamma-crystallin superfamily. J Biol Chem (1986) 2.31

Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell (1998) 2.31

Calcium and cAMP activate different chloride channels in the apical membrane of normal and cystic fibrosis epithelia. Proc Natl Acad Sci U S A (1991) 2.30

Characterization of the split hand/split foot malformation locus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development. Hum Mol Genet (1996) 2.29

Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science (1987) 2.27

Permeability of wild-type and mutant cystic fibrosis transmembrane conductance regulator chloride channels to polyatomic anions. J Gen Physiol (1997) 2.26

Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol (1991) 2.25

Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24

cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Invest (1992) 2.23

Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains. Science (1992) 2.18

Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci U S A (1998) 2.16

Characterization of human tracheal epithelial cells transformed by an origin-defective simian virus 40. Proc Natl Acad Sci U S A (1988) 2.15

Cloning and expression of a novel human brain Na+ channel. J Biol Chem (1996) 2.14

Effect of deleting the R domain on CFTR-generated chloride channels. Science (1991) 2.09

Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics (1991) 2.07

Cloning, expression, and tissue distribution of a human amiloride-sensitive Na+ channel. Am J Physiol (1994) 2.07

Isolation, characterization, and localization of the inositol 1,4,5-trisphosphate receptor protein in Xenopus laevis oocytes. J Biol Chem (1992) 2.05

Effect of ATP concentration on CFTR Cl- channels: a kinetic analysis of channel regulation. Biophys J (1994) 1.99

Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time. J Virol (1996) 1.98

Activity of abundant antimicrobials of the human airway. Am J Respir Cell Mol Biol (1999) 1.93

Localization of cystic fibrosis transmembrane conductance regulator in chloride secretory epithelia. J Clin Invest (1992) 1.93

Methods for analysis of multiple cystic fibrosis mutations. Hum Genet (1991) 1.88

Calcium-activated potassium channels in canine airway smooth muscle. J Physiol (1986) 1.87

A molecular component of the arterial baroreceptor mechanotransducer. Neuron (1998) 1.87

The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nat Genet (1999) 1.87

Cystic fibrosis decreases the apical membrane chloride permeability of monolayers cultured from cells of tracheal epithelium. Proc Natl Acad Sci U S A (1985) 1.87